HOME › DRUGS › HUMAN FIBRINOGEN;HUMAN THROMBIN
ACTIVE SUBSTANCE / INN

HUMAN FIBRINOGEN;HUMAN THROMBIN

Brand name(s): Evarrest, TachoSil, Evicel, VeraSeal, Raplixa
EMA LISTED
WITHDRAWN
AUTHORISED
Hemostasis
Hemostasis, Surgical
ACTIVE SUBSTANCE
Human Fibrinogen;Human Thrombin
REGULATORS
EMA
SPONSORS / MAH
Instituto Grifols, S.A., Mallinckrodt Pharmaceuticals Ireland Limited, Corza Medical GmbH
TOTAL APPLICATIONS
5
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
TachoSilCorza Medical GmbHAuthorised08/06/2004Hemostasis, Surgical
VeraSealInstituto Grifols, S.A.Authorised10/11/2017Hemostasis, Surgical
EvicelOmrix Biopharmaceuticals N. V.Withdrawn05/10/2008Hemostasis, Surgical
RaplixaMallinckrodt Pharmaceuticals Ireland LimitedWithdrawn19/03/2015Hemostasis, Surgical
EvarrestOmrix Biopharmaceuticals N. V.Withdrawn25/09/2013Hemostasis

FULL INTELLIGENCE ON HUMAN FIBRINOGEN;HUMAN THROMBIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →